Key Takeaways WGS is projected to post Q2 revenues of $84.7M, up 20.1% from the prior-year quarter.Pediatric neurology and new testing indications likely fueled outpatient volume growth for GeneDx.WGS' Q2 gains may stem from AI-driven Fabric Genomics buyout and launch of ultraRapid sequencing.GeneDx Holdings Corp. (WGS) is slated to report second-quarter 2025 results on July 29, before the market opens.The renowned genetic testing company reported first-quarter adjusted earnings of 28 cents per share, which ...